RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      Utilization of retro-inverso peptide ligand of Transferrin receptor for enhanced polymer-based liver-targeted gene delivery

      한글로보기

      https://www.riss.kr/link?id=T17374092

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

      Liver-targeted gene therapy offers great promise for the treatment of hepatic disorders; however, its clinical progress has been hindered by the lack of vectors that can ensure both safety and high delivery efficiency. The 25 kDa branched polyethylenimine (BPEI) polymer has long been recognized as an effective non-viral vehicle because of its remarkable buffering capacity and ability to facilitate endosomal escape. Nevertheless, its non-selective interactions with biological components often result in systemic toxicity, restricting its use in therapeutic applications. To overcome these drawbacks, a hepatocyte-specific carrier system was designed by covalently linking BPEI25K to peptides that mimic the transferrin receptor (TfR) ligand, taking advantage of the receptor’s elevated expression on liver cells. Two types of peptides were employed for this purpose: the native L-form peptide (HAIYPRH) and a retro-inverso D-form variant (HRPYIAH) that exhibits improved resistance to enzymatic degradation. These conjugates, referred to as BPEI–TfRL and BPEI–TfRD, were synthesized and complexed with plasmid DNA (pDNA) to form nanoscale polyplexes. Both polymer conjugates efficiently condensed pDNA into stable nanoparticles with a positive surface charge at an optimal polymer-to-DNA ratio of 15:1 (w/w). When evaluated in AML-12 murine hepatocytes, the unmodified BPEI showed minimal gene transfer capability. In contrast, both TfR-modified carriers enhanced transfection outcomes, with BPEI–TfRD producing the strongest gene expression. This was evident from pronounced GFP fluorescence observed at 24 h and 48 h post-transfection and from a significant elevation in S1P1R mRNA levels. Overall, these findings suggest that the D-form peptide-conjugated BPEI platform holds substantial potential as a selective and efficient vector for liver-specific gene therapy.
      번역하기

      Liver-targeted gene therapy offers great promise for the treatment of hepatic disorders; however, its clinical progress has been hindered by the lack of vectors that can ensure both safety and high delivery efficiency. The 25 kDa branched polyethyleni...

      Liver-targeted gene therapy offers great promise for the treatment of hepatic disorders; however, its clinical progress has been hindered by the lack of vectors that can ensure both safety and high delivery efficiency. The 25 kDa branched polyethylenimine (BPEI) polymer has long been recognized as an effective non-viral vehicle because of its remarkable buffering capacity and ability to facilitate endosomal escape. Nevertheless, its non-selective interactions with biological components often result in systemic toxicity, restricting its use in therapeutic applications. To overcome these drawbacks, a hepatocyte-specific carrier system was designed by covalently linking BPEI25K to peptides that mimic the transferrin receptor (TfR) ligand, taking advantage of the receptor’s elevated expression on liver cells. Two types of peptides were employed for this purpose: the native L-form peptide (HAIYPRH) and a retro-inverso D-form variant (HRPYIAH) that exhibits improved resistance to enzymatic degradation. These conjugates, referred to as BPEI–TfRL and BPEI–TfRD, were synthesized and complexed with plasmid DNA (pDNA) to form nanoscale polyplexes. Both polymer conjugates efficiently condensed pDNA into stable nanoparticles with a positive surface charge at an optimal polymer-to-DNA ratio of 15:1 (w/w). When evaluated in AML-12 murine hepatocytes, the unmodified BPEI showed minimal gene transfer capability. In contrast, both TfR-modified carriers enhanced transfection outcomes, with BPEI–TfRD producing the strongest gene expression. This was evident from pronounced GFP fluorescence observed at 24 h and 48 h post-transfection and from a significant elevation in S1P1R mRNA levels. Overall, these findings suggest that the D-form peptide-conjugated BPEI platform holds substantial potential as a selective and efficient vector for liver-specific gene therapy.

      더보기

      목차 (Table of Contents)

      • Abstract 1
      • Introduction 4
      • Material and Methods 15
      • Results 22
      • Discussion 57
      • Abstract 1
      • Introduction 4
      • Material and Methods 15
      • Results 22
      • Discussion 57
      • Conclusion 61
      • References 63
      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼